Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment

References

• Raine T, Verstockt B, and Kopylov U, et al. ECCO Topical Review: Refractory Inflammatory Bowel Disease J Crohns Colitis. 2021Jun23;15(10) :1605–1620 doi:https://doi.org/10.1093/ecco-jcc/jjab112.
   PubMed Web of Science ®Google Scholar
• Siegmund B. Cytomegalovirus infection associated with inflammatory bowel disease. Lancet Gastroenterol Hepatol. 2017;2(5):369–376.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Traboulsi C, Rai V. A practical clinical approach to the management of high-risk ulcerative colitis. Gastroenterol Hepatol. 2021;17(2):59–66.
   Google Scholar
• Sager K, Alam S, Bond A, et al. Review article: cytomegalovirus and inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(8):725–733.
   PubMed Web of Science ®Google Scholar
• Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010 Jul;20(4):202–213.
   PubMed Web of Science ®Google Scholar
• Römkens TE, Bulte GJ, Nissen LH, et al. Cytomegalovirus in inflammatory bowel disease: a systematic review. World J Gastroenterol. 2016 Jan 21;22(3):1321–1330.
   PubMed Web of Science ®Google Scholar
• Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006 Dec;101(12):2857–2865.
   PubMed Web of Science ®Google Scholar
• Shimada T, Nagata N, Okahara K, et al. PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: comparison with individuals with immunocompetency and HIV infection. PLoS One. 2017 Sep 13;12(9):e0184699.
   PubMed Web of Science ®Google Scholar
• Wada Y, Matsui T, Matake H, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum. 2003 Oct;46(10 Suppl):S59–65.
   PubMed Web of Science ®Google Scholar
• Iyer VH, Augustine J, Pulimood AB, et al. Correlation between coinfection with parasites, cytomegalovirus, and Clostridium difficile and disease severity in patients with ulcerative colitis. Indian J Gastroenterol. 2013 Mar;32(2):115–118.
   PubMedGoogle Scholar
• Kuwabara A, Okamoto H, Suda T, et al. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007 Oct;42(10):823–829.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Simpson N, Klipfel N, et al. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010 Apr;55(4):1059–1065.
   PubMed Web of Science ®Google Scholar
• Weng MT, Tung CC, Lee YS, et al. Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study. BMC Gastroenterol. 2017 Feb 13;17(1):28.
   PubMed Web of Science ®Google Scholar
• Bontà J, Zeitz J, Frei P, et al. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience. Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1329–1334.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim YH, Kim JS, et al., IBD Study Group of the Korean Association for the Study of Intestinal Diseases(KASID), Korea. Cytomegalovirus infection in patients with new onset ulcerative colitis: a prospective study. Hepatogastroenterology. 2012 Jun;59(116):1098–1101.
   PubMedGoogle Scholar
• Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis. 2014 Jul;8(7):693–701.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim YH, Kim JS, et al., IBD Study Group of the Korean Association for the Study of Intestinal Diseases. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol. 2012 Jan;46(1):51–56.
   PubMed Web of Science ®Google Scholar
• Domènech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008 Oct;14(10):1373–1379.
   PubMed Web of Science ®Google Scholar
• Yadegarynia D, Tehrani S, Roohi M, et al. Prevalence of cytomegalovirus infection in patients with ulcerative colitis: a prospective cross-sectional study in Tehran, Iran. Iran J Microbiol. 2018 Oct;10(5):342–347.
   PubMed Web of Science ®Google Scholar
• Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011 Nov;106(11):2001–2008.
   PubMed Web of Science ®Google Scholar
• Criscuoli V, Rizzuto MR, Montalbano L, et al. Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis. World J Gastroenterol. 2011 Feb 7;17(5):633–638.
   PubMed Web of Science ®Google Scholar
• Tun GSZ, Raza M, Hale MF, et al. Polymerase chain reaction for detection of mucosal cytomegalovirus infection in patients with acute ulcerative colitis. Ann Gastroenterol. 2019 Jan-Feb;32(1):81–87.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Tange T. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Colon Rectum. 2004;47(5):722–726.
   PubMed Web of Science ®Google Scholar
• Römkens TE, Bulte GJ, Nissen LH, et al. Cytomegalovirus in inflammatory bowel disease: a systematic review. World J Gastroenterol. 2016;22(3):1321–1330.
   PubMed Web of Science ®Google Scholar
• Garrido E, Carrera E, Manzano R, et al. Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease. World J Gastroenterol. 2013;19(1):17–25.
   PubMed Web of Science ®Google Scholar
• Powell RD, Warner NE, Levine RS, et al. Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med. 1961 Feb;30(2):1373–1379.
   Web of Science ®Google Scholar
• Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010;16(9):1620–1627.
   PubMed Web of Science ®Google Scholar
• Collins-mcmillen D, Kamil J, Moorman N, et al. Control of immediate early gene expression for human cytomegalovirus reactivation. Front Cell Infect Microbiol. 2020 Sep 17;10:476.
   PubMed Web of Science ®Google Scholar
• Hommes DW, Sterringa G, van Deventer SJ, et al. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis. 2004 May;10(3):245–250.
   PubMed Web of Science ®Google Scholar
• Varani S, Landini MP. Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae. 2011 Apr 7;2(1):6.
   PubMedGoogle Scholar
• Wang YQ, Zhao XY. Human cytomegalovirus primary infection and reactivation: insights from virion-carried molecules. Front Microbiol. 2020;11:1511. Published 2020 Jul 14.
   PubMed Web of Science ®Google Scholar
• Wang S, Dou Y, Yang H, et al. Alteration of glucocorticoid receptors and exacerbation of inflammation during lytic cytomegalovirus infection in THP-1 cells.FEBS Open Bio. 2017 [Published 2017 Oct 30];7(12):1924–1931.
   PubMed Web of Science ®Google Scholar
• Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004 Nov;53(11):1155–1160.
   PubMed Web of Science ®Google Scholar
• Gauss A, Rosenstiel S, Schnitzler P, et al. Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience. Eur J Gastroenterol Hepatol. 2015 Jun;27(6):712–720.
   PubMed Web of Science ®Google Scholar
• Hirayama Y, Ando T, Hirooka Y, et al. Characteristic endoscopic findings and risk factors for cytomegalovirus-associated colitis in patients with active ulcerative colitis. World J Gastrointest Endosc. 2016 Mar 25;8(6):301–309.
   PubMedGoogle Scholar
• Nowacki TM, Bettenworth D, Meister T, et al. Novel score predicts risk for cytomegalovirus infection in ulcerative colitis. J Clin Virol. 2018 Aug;105:103–108.
   PubMed Web of Science ®Google Scholar
• Yang H, Wu K, Zhang H, et al. and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis. BMC Gastroenterol. 2020 Sep 5;20(1):294.
   PubMed Web of Science ®Google Scholar
• Störkmann H, Rödel J, Stallmach A, et al. Are CMV-predictive scores in inflammatory bowel disease useful in clinical practice? Z Gastroenterol. 2020 Sep;58(9):868–871.
   PubMed Web of Science ®Google Scholar
• McCurdy JD, Jones A, Enders FT, et al. A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2015Jan;13(1):131–137. quiz e7. *Predictive score for identifying high risk.
   PubMed Web of Science ®Google Scholar
• Qin Y, Wang G, Kong D, et al. Risk factors of cytomegalovirus reactivation in ulcerative colitis patients: a meta-analysis. Diagnostics (Basel). 2021 [Published 2021 Oct 21];11(11):1952.
   PubMedGoogle Scholar
• Seo TH, Kim JH, Ko SY, et al. Cytomegalovirus colitis in immunocompetent patients: a clinical and endoscopic study. Hepatogastroenterology. 2012;59(119):2137–2141.
   PubMedGoogle Scholar
• Wetwittayakhlang P, Rujeerapaiboon N, Wetwittayakhlung P, et al. Clinical features, endoscopic findings, and predictive factors for mortality in tissue-invasive gastrointestinal cytomegalovirus disease between immunocompetent and immunocompromised patients. Gastroenterol Res Pract. 2021 [Published 2021 Apr 6];2021:8886525.
   PubMed Web of Science ®Google Scholar
• Lee HS, Park SH, Kim SH, et al. Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis. 2016;22(4):912–918.
   PubMed Web of Science ®Google Scholar
• Schenk W, Klugmann T, Borkenhagen A, et al. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic. Int J Colorectal Dis. 2019;34(3):393–400.
   PubMed Web of Science ®Google Scholar
• McCurdy JD, Enders FT, Khanna S, et al. Increased rates of clostridium difficile infection and poor outcomes in patients with IBD with cytomegalovirus. Inflamm Bowel Dis. 2016 Nov;22(11):2688–2693.
   PubMed Web of Science ®Google Scholar
• Del Valle JP, Lee GC, Serrato JC, et al. Recurrence of clostridium difficile and cytomegalovirus infections in patients with ulcerative colitis who undergo ileal pouch-anal anastomosis. Dig Dis Sci. 2021 Jan 12;66(12):4441–4447.
   PubMed Web of Science ®Google Scholar
• Pediatric IBD Porto Group of ESPGHAN, Cohen S, Martinez-Vinson C, Aloi M, et al. Cytomegalovirus infection in pediatric severe ulcerative Colitis-A multicenter study from the pediatric inflammatory bowel disease porto group of the European society of pediatric gastroenterology, hepatology and nutrition. Pediatr Infect Dis J. 2018 Mar;37(3):197–201.
   PubMed Web of Science ®Google Scholar
• Jain S, Namdeo D, and Sahu P, et al. High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis. Intest Res. 2020 Nov 6;19(4): 438–447 .
   PubMed Web of Science ®Google Scholar
• Oh SJ, Lee CK, Kim YW, et al. True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center. Scand J Gastroenterol. 2019 Aug;54(8):976–983.
   PubMed Web of Science ®Google Scholar
• Delvincourt M, Lopez A, Pillet S, et al. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2014 Apr;39(7):712–720.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kato J, Kuriyama M, et al. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol. 2010 Mar 14;16(10):1245–1251.
   PubMed Web of Science ®Google Scholar
• Inokuchi T, Kato J, Hiraoka S, et al. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status. World J Gastroenterol. 2014 Jan 14;20(2):509–517.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver. 2014 Nov;8(6):643–647.
   PubMed Web of Science ®Google Scholar
• Okahara K, Nagata N, Shimada T, et al. Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis. PLoS One. 2017 Sep 8;12(9):e0183951.
   PubMed Web of Science ®Google Scholar
• Henmi Y, Kakimoto K, Inoue T, et al. Cytomegalovirus infection in ulcerative colitis assessed by quantitative polymerase chain reaction: risk factors and effects of immunosuppressants. J Clin Biochem Nutr. 2018 Nov;63(3):246–251.
   PubMed Web of Science ®Google Scholar
• Zagórowicz E, Bugajski M, Wieszczy P, et al. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J Crohns Colitis. 2016 Oct;10(10):1205–1211.
   PubMed Web of Science ®Google Scholar
• Hendler SA, Barber GE, Okafor PN, et al. Cytomegalovirus infection is associated with worse outcomes in inflammatory bowel disease hospitalizations nationwide. Int J Colorectal Dis. 2020 May;35(5):897–903.
   PubMed Web of Science ®Google Scholar
• Kojima T, Watanabe T, Hata K, et al. Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol. 2006 Jun;41(6):706–711.
   PubMed Web of Science ®Google Scholar
• Minami M, Ohta M, Ohkura T, et al. Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. World J Gastroenterol. 2007 Feb 7;13(5):754–760.
   PubMed Web of Science ®Google Scholar
• Al-Zafiri R, Gologan A, Galiatsatos P, et al. Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol. 2012 Apr;8(4):230–239.
   Google Scholar
• Olaisen M, Rydning A, Martinsen TC, et al. Cytomegalovirus infection and postoperative complications in patients with ulcerative colitis undergoing colectomy. Scand J Gastroenterol. 2014 Jul;49(7):845–852.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhou W, Lv H, et al. The association between CMV viremia or endoscopic features and histopathological characteristics of CMV colitis in patients with underlying ulcerative colitis. Inflamm Bowel Dis. 2017 May;23(5):814–821.
   PubMed Web of Science ®Google Scholar
• Wang XZ, Yang H, Pang JY, et al.Different viral doses of cytomegalovirus infection in the left and right colons.Zhonghua Bing Li Xue Za Zhi.2020Jun8;49(6):583–587. Chinese.
   PubMedGoogle Scholar
• Ross SA, Novak Z, Pati S, et al. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets. 2011;11(5):466–474.
   PubMedGoogle Scholar
• Ciccocioppo R, Racca F, Paolucci S, et al. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. World J Gastroenterol. 2015 Feb 14;21(6):1915–1926.
   PubMed Web of Science ®Google Scholar
• Zidar N, Ferkolj I, Tepeš K, et al. Diagnosing cytomegalovirus in patients with inflammatory bowel disease–by immunohistochemistry or polymerase chain reaction? Virchows Arch. 2015 May;466(5):533–539.
   PubMed Web of Science ®Google Scholar
• McCurdy JD, Enders FT, Jones A, et al. Detection of cytomegalovirus in patients with inflammatory bowel disease: where to biopsy and how many biopsies? Inflamm Bowel Dis. 2015 Dec;21(12):2833–2838.
   PubMed Web of Science ®Google Scholar
• Park SC, Jeen YM, Jeen YT. Approach to cytomegalovirus infections in patients with ulcerative colitis [published correction appears in Korean. J Intern Med. 2021 May;36(3):751. Korean J Intern Med. 2017;32(3):383-392.
   Web of Science ®Google Scholar
• Mourad FH, Hashash JG, Kariyawasam VC, et al. Ulcerative Colitis and Cytomegalovirus Infection: from A to Z. J Crohns Colitis. 2020Sep7;14(8):1162–1171.
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Iwao Y, Mori T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007 Feb;102(2):331–337.
   PubMed Web of Science ®Google Scholar
• Nguyen M, Bradford K, Zhang X, et al. Cytomegalovirus reactivation in ulcerative colitis patients. Ulcers. 2011. 2011 Jan 1. 2011:282507.
   PubMedGoogle Scholar
• Kopylov U, Papamichael K, Katsanos K, et al. Impact of infliximab and cyclosporine on the risk of colectomy in hospitalized patients with ulcerative colitis complicated by cytomegalovirus-A multicenter retrospective study. Inflamm Bowel Dis. 2017 Sep;23(9):1605–1613.
   PubMed Web of Science ®Google Scholar
• Shukla T, Singh S, Tandon P, et al. Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2017 May;51(5):394–401.
   PubMed Web of Science ®Google Scholar
• Bonfanti E, Bracco C, Biancheri P, et al. Fever during anti-integrin therapy: new immunodeficiency. Eur J Case Rep Intern Med. 2020 Feb 11;7(3):001288.
   PubMedGoogle Scholar
• Hommel C, Pillet S, Rahier JF. Comment on: ‘Resolution of CMV infection in the bowel on vedolizumab therapy.’ J Crohns Colitis. 2020 Jan 1;14(1):148–149.
   PubMed Web of Science ®Google Scholar
• Rawa-Gołębiewska A, Lenarcik M, Zagórowicz E. Resolution of CMV infection in the bowel on vedolizumab therapy. J Crohns Colitis. 2019 Sep 19;13(9):1234–1235.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Panés J, D’Haens GR, et al. Safety of tofacitinib for treatment of ulcerative colitis, based on 4.4 years of data from global clinical trials. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1541–1550.
   PubMed Web of Science ®Google Scholar
• Sands BE, Sandborn WJ, Panaccione R, et al. UNIFI Study Group. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med.2019 Sep 26;381(13):1201–1214.
   PubMed Web of Science ®Google Scholar
• Tamura S, Osawa S, Ishida N, et al. Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis. Sci Rep. 2021 Jul 1;11(1):13676.
   PubMed Web of Science ®Google Scholar
• Shukla T, Singh S, Loftus EV Jr, et al. Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis. Inflamm Bowel Dis. 2015 Nov;21(11):2718–2725.
   PubMed Web of Science ®Google Scholar
• Jones A, McCurdy JD, Loftus EV Jr, et al. Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirus. Clin Gastroenterol Hepatol. 2015 May;13(5):949–955.
   PubMed Web of Science ®Google Scholar
• Wang Y, Aggarwal P, Liu X, et al. Antiviral treatment for colonic cytomegalovirus infection in ulcerative colitis patients significantly improved their surgery free survival. J Clin Gastroenterol. 2018 Apr;52(4):e27–e31.
   PubMed Web of Science ®Google Scholar
• Kochan K, Keskin EB, Seven G, et al. Effects of tissue cytomegalovirus quantitative polymerase chain reaction in the management of ulcerative colitis flare-ups: should we wave aside? Arab J Gastroenterol. 2021 [published online ahead of print, Dec 3];S1687-1979(21):83–86.
   Google Scholar
• Choi CH, Moon W, Kim YS, et al., IBD Study Group of the Korean Association for the Study of Intestinal Diseases. Second Korean guidelines for the management of ulcerative colitis. Intest Res. 2017 Jan;15(1):7–37.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Kennedy NA, Raine T, et al., . British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019 Dec;68(Suppl 3):s1–s106. Epub 2019 Sep 27 Erratum in: Gut. 2021 Apr;70(4):1.
   PubMed Web of Science ®Google Scholar
• Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019 Mar;114(3):384–413.
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Ellul P, Greuter T, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021Jun22;15(6):879–913.
   PubMed Web of Science ®Google Scholar
• Wethkamp N, Nordlohne EM, Meister V, et al. Identification of clinically relevant cytomegalovirus infections in patients with inflammatory bowel disease. Mod Pathol. 2018;31(3):527–538.
   PubMed Web of Science ®Google Scholar
• Nahar S, Iraha A, Hokama A, et al.Evaluation of a multiplex PCR assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis.World J Gastroenterol.2015Nov28;21(44):12667–12675. Erratum in: World J Gastroenterol. 2018 Feb 21;24(7):876
   PubMed Web of Science ®Google Scholar
• Tarasewicz A, A D-Ś, Rutkowski B. Clinical utility of QuantiFERON-Cytomegalovirus test in management of kidney transplant recipients. Transplant Proc. 2016 Jun;48(5):1650–1653.
   PubMed Web of Science ®Google Scholar
• Boom R, Sol C, Weel J, et al. Detection and quantitation of human cytomegalovirus DNA in faeces. J Virol Methods. 2000 Jan;84(1):1–14.
   PubMed Web of Science ®Google Scholar
• Magdziak A, Szlak J, Mróz A, et al. A stool test in patients with active ulcerative colitis helps exclude cytomegalovirus disease. Scand J Gastroenterol. 2020 Jun;55(6):664–670.
   PubMed Web of Science ®Google Scholar
• Fukuchi T, Nakase H, Matsuura M, et al. Effect of intensive granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis positive for cytomegalovirus. J Crohns Colitis. 2013 Nov;7(10):803–811.
   PubMed Web of Science ®Google Scholar
• Karolewska-Bochenek K, Lazowska-Przeorek I, Grzesiowski P, et al. Faecal microbiota transfer - a new concept for treating cytomegalovirus colitis in children with ulcerative colitis. Ann Agric Environ Med. 2021 Mar 18;28(1):56–60.
   PubMed Web of Science ®Google Scholar